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1. INTRODUCTION 
Cholesterol is a major component of the plasma 
membrane of mammalian cells (11, including 
human red blood cells which have a 
cholesterol :phospholipid molar ratio of 0.8 [2]. 
Cholesterol modulates the fluidity of the mem- 
brane by ordering liquid-crystalline state 
phospholipids and by disordering gel state 
phospholipid [3-81. In model and biological mem- 
branes in the liquid-crystalline state, cholesterol 
reduces the non-electrolyte permeability of the 
lipid bilayer [9-l 11. Cholesterol also affects the ac- 
tivity of membrane-associated enzymes. Enrich- 
ment of red bloods with cholesterol by incubation 
with cholesterol-containing liposomes [ 12,131 
results in inhibition of Na+,K+ co-transport [14]. 
The Na+/K+ ATPase activity was enhanced by 
cholesterol depletion [ 151, and inhibited by 
cholesterol enrichment [ 161. The membrane 
cholesterol content of erythrocytes has been shown 
to affect anion transport, as measured by sulfate 
exchange [17] and by pyruvate-chloride exchange 
[18]. Cholesterol has also been suggested to affect 
the stability [3,19-2 11, and microviscosity [ 13,221 
of the red cell membrane and the exposure and 
distribution of its membrane proteins [22,23]. 
studied. Membrane cholesterol evels were altered 
by incubation of erythrocytes with liposomes con- 
taining various amounts of cholesterol [12,13] or 
by converting the membrane cholesterol to 
cholest-4-en3one by exposing cells to cholesterol 
oxidase [20,21]. The effect of cholestenone on 
anion transport was also determined by enriching 
cells with this cholesterol derivative. The 
temperature-dependence of phosphate uptake into 
erythrocytes containing various levels of 
cholesterol was determined. It was found that 
anion transport was inhibited by cholesterol 
enrichment. However, cholestenone had very 
similar effects. This suggests that there is not a 
specific interaction between cholesterol and Band 
3, the anion transport protein. 
2. MATERIALS AND METHODS 
Outdated human red blood cells were kindly 
provided by the Canadian Red Cross (Edmonton, 
Alberta). Cholesterol, egg phosphatidylcholine, 
cholestenone and penicillin were obtained from 
Sigma. Cholesterol oxidase was a product from 
Boehringer-Mannheim. t3*P]phosphate was ob- 
tained from New England Nuclear. 
In the experiments reported here, the effect of 
cholesterol on anion transport, as measured by 
phosphate uptake into human red blood cells was 
* Alberta Heritage Foundation for Medical Research 
Postdoctoral Fellow 
+ Scholar of the Medical Research Council of Canada 
Cells were washed 3-times in buffer A, 28.5 mM 
sodium citrate, 205,3 mM sucrose (pH 7.4) and 
suspended (25% hematocrit) in buffer B 150 mM 
NaCl, 5 mM KCl, 6.3 mM sodium phosphate, 
0.5 mM CaC12, 10 mM glucose, penicillin, 
1000 PM/ml; pH 7.4. Liposomal suspensions were 
made as in [17]. Enrichment suspensions, contain- 
ing 150 mg’ egg phosphatidyl choline and 190 mg 
cholesterol (C/P = 2.5) dissolved in benzene, were 
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lyophilized to dryness, suspended in 10 ml buffer 
B and sonicated for 1 h at 4°C. The sonicated mix- 
ture was centrifuged with albumin added to the 
solution (5 mg/ml) at 35000 x g for 30 min at 4°C 
to remove vanadium particles. The supernatant 
was diluted with buffer B (containing 5 mg/ml 
albumin) to a final concentration of about 6 mg 
lipid/ml. Depletion suspensions contained 350 mg 
egg phosphatidyl choline and were prepared as 
above; cholestenone nrichment suspensions con- 
tained SO-100 mg cholestenone, O-100 mg 
cholesterol, and 100 mg egg PC. Celis were in- 
cubated with an equal volume of liposomal suspen- 
sion at 37°C in a shaking water bath for 5-10 h 
(depletion), 18-24 h (enrichment), or l-20 h 
(cholestenone nrichment). 
2.1 I) treatment with ch~leste~~~ oxidase 
Control and enriched cells were exposed to 
cholesterol oxidase as in [20,21], Cells were washed 
in 12 vol. buffer C, 0.5 mM sodium phosphate, 
310 mM sucrose (pH 7.5) at 4”C, suspended in 
buffer C (10% hematocrit), and equilibrated at 
37°C in a shaking water bath. Enzyme was added 
(l-10 units/ml) and cells were incubated for 
60 min. At the end of the incubation, cells were 
cooled on ice and washed twice with buffer A. 
22, Phosphate uptake assay 
Washed cells were diluted to 50% hematocrit 
with buffer A and equilibrated at 30°C in a shak- 
ing water bath for 5 min. To start the assay, 25 $1 
of buffer A containing [32P]phosphate (0.02 Ci/pl) 
was added to cells, the suspension was quickly 
vortexed and returned to water bath. At 5, 10, 15, 
20, 30,45, 60, 90 and 120 min, cells were vortexed 
and a 0.125-ml aliquot taken. Aliquots were 
transferred to a 1 ml Eppendorf microfuge tube, 
centrifuged for 2 min in an Eppendorf microfuge, 
and two 25 pl aliquots of the supernatant aken. 
The supernatant aliquots were added to scintilla- 
tion vials and counted in 5 ml Aquasol. 
2.3. Effect of temperature on phosphate uptake 
Phosphate uptake assays were performed for 
control, enriched and depleted cells for a range of 
temperatures (lo-38°C) as described above. Cell 
suspensions were sampled at various time intervals 
after addition of [32Pjphosphate, depending on 
assay temperature, according to the fo~owing 
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schedule: 1,2 and 3 h for cells at lo-20°C; 30, 60 
and 120 min for cells at 22 and 24V; 15, 30 and 
60 min for cells at 26 and 28°C; 5, 10 and 20 min 
for cells at 30 and 32*C; 2,4,8 and 10 min for cells 
at 34 and 36°C; and 1, 2, 4 and 6 min for cells at 
38°C. 
2.4. Chemical assays 
Cell membranes were purified by Iysis of cells in 
5 vol. ice-cold 5P8 buffer (5 mM sodium 
phosphate, pH 8), and repeated centrifugation at 
15000 rev./min for 20 min at 4’C [24]. Mem- 
branes were analyzed for protein as in [25]. Mem- 
brane lipids were extracted by adding 1 vol. mem- 
branes to 5 vol. methanol while vortexing. The 
mixture was left on ice for 20 min, then an equal 
volume of chloroform was added while vortexing 
solution. Mixture was again left on ice for 20 min, 
then centrifuged at 2000 rev./min for 5 min at 
4°C. The supernatant was decanted into a large 
test tube and the extraction process repeated with 
2 vol. of each solvent with the resuspended pellet. 
The pooled supernatant was adjusted so that final 
proportions of chloroform : methanol :water were 
10 : 5 : 1. The solution was vortexed and centrifuged 
at 5000 rev./min for 10 min at 4% and the upper 
phase was removed. The organic phase was 
evaporated to dryness under a stream of nitrogen 
and Iipids were resuspended in chloroform. Equal 
volumes of lipid were dispensed into test tubes for 
the lipid analyses. Cholesterol was analyzed as in 
[26] except that absorbance was read at 620 nm. 
Phospholipid content was determined by a 
modification of the method in [27]. The lipid sam- 
ple was evaporated under a stream of nitrogen and 
resuspended in 0.5 ml chloroform which was plac- 
ed in a boiling water bath until dry. To the test 
tube were added 0.4 ml chloroform and 0.2 ml 
chromogenic solution. The tube was vortexed and 
placed in boiling water for 2-3 min. When the 
tube was cool, 3 ml of chloroform containing 3% 
methanol was added, the mixture was vortexed and 
centrifuged on a table top centrifuge for 5 min. 
Absorbance was read at 716 nm. Cholestenone 
was analyzed by the modification in [28] of the 
method in [29]. Membrane protein was analyzed 
by SDS-polyacrylamide gel electrophoresis [30] 
and quantitated by scanning the gels and measur- 
ing the relative peak areas. 
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3. RESULTS AND DISCUSSION Table 1 
The cholesterol:phospholipid ratio in the red 
cell membrane could be varied from 0.4 to 1.5 
(fig.1) by incubating the cells with 
phosphatidylcholine liposomes containing various 
amounts of cholesterol. The level of cholesterol in 
the membrane was found to affect phosphate up- 
take into chloride-loaded cells (fig. 1). Transport 
was inhibited at high cholesterol levels and 
stimulated at low cholesterol evels. A straight line, 
fitted by linear regression analysis, with a correla- 
tion coefficient of 0.75 could be drawn through the 
data points. Non-linear lines could also be fitted to 
the data. The effects of cholesterol on phosphate 
transport are fully reversible (table 1). Cells enrich- 
ed with cholesterol could be depleted of cholesterol 
with an increase in transport. The protein profiles 
of normal cholesterol-enriched or depleted mem- 
branes were very similar, showing that little extrac- 
tion or proteolytic degradation of membrane pro- 
teins occurred during the prolonged incubations 
(not shown). 
The activity of some membrane-bound enzymes 
is sensitive to the phase state of the membrane lipid 
[3 11. Studies of the temperature dependence of the 
transport or enzymatic activities of membrane pro- 
teins have produced curved or multiphasic Ar- 
rhenius plots [31]. The temperature at which a 
06 
1 
I , 1 I 1 
0.4 0.6 0.8 1.0 12 1.4 1.6 
C/P Ratio 
Fig. 1. Effect of the cholesterol content of the membrane 
on phosphate uptake into red blood cells. C/P: 
cholesterol/phospholipid molar ratio. The cholesterol 
content of the membrane was modified as described in 
section 2. 
Reversibility of the effect of cholesterol on phosphate 
uptake 
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change in activation energy occurs can sometimes 
be related to phase changes in the lipid, although 
in other cases no correlation with a lipid transition 
can be established. No cooperative phase transi- 
tion could be detected in red cell membranes or 
total lipids by differential scanning calorimetry [4]. 
2H-NMR [32], “P-NMR [33] and fluorescence 
polarization studies using the extrinsic probe, 
1,6-diphenyl-1,3,5-hexatriene [33], have indicated 
that the lipid of the erythrocyte membrane is in the 
liquid-crystalline phase at all temperatures above 
- YC, with no evidence for lateral phase separa- 
tions. A broad phase transition extending from 
- 20 to t 10°C could be detected in erythrocyte 
membranes by Raman spectroscopy and a sharp 
transition was detected at 17°C using&carotene as 
an extrinsic probe [34]. In [35] a small viscosity 
change was detected at 18-19°C. X-ray diffraction 
[23,36] showed that the membrane contained no 
gel state lipid above - 2O”C, although lowering the 
cholesterol phospholipid ratio to 0.5 raised the 
upper boundary of a phase transition from 
<0-20°C [23,26]. Membranes depleted of 
cholesterol by ether extraction also showed a tran- 
sition at 20°C by “P-NMR [33]. Normal red cell 
membranes therefore do not appear to undergo a 
sharp phase transition above O’C. Reducing the 
cholesterol evel of the membrane moves the upper 
boundary of a broad phase transition to about 
20°C. 
The effect of changing the cholesterol level of 
the membrane on the temperature-dependence of 
phosphate transport was determined. As shown in 
fig.2, Arrhenius plots of phosphate uptake in nor- 
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Fig.2. Arrhenius plot of phosphate uptake into red 
blood cells. (0) control cells, C/P = 0.8; (A) 
cholesterol-depleted c lls, C/P = 0.5; (0) cholesterol- 
enriched cells, C/P = 1.4. 
mal, cholesterol-enriched and cholesterol-depleted 
membranes produced straight, parallel lines from 
lo-40°C. An activation energy of 27.2 kcal/mol 
was calculated. The authors of a study of the 
temperature-dependence of chloride-bicarbonate 
exchange in human erythrocyte suggested that a 
break in the Arrhenius plot occurred at 20°C [37]. 
The activation energy is 12 kcal/mol above this 
temperature, and 20 kcal/mol below this 
temperature. A similar change in activation energy 
was suggested for chloride exchange [38] where the 
apparent activation energy decreased from 
30 kcal/mol to 20 kcal/mol above a temperature 
of 15°C. A close examination of the data in these 
references [37,38] reveals that the Arrhenius plots 
could also be fitted to curvilinear lines without 
sharp breaks. No such curve or break in the Ar- 
rhenius plot was observed for phosphate uptake 
even with cholesterol-depleted membranes sug- 
gesting that the phosphate transport is unaffected 
by the change in the rate-limiting step that affected 
chloride and bicarbonate transport. This may be 
due to the fact that phosphate is transported 
lo’-times more slowly than chloride [39]. No 
change in the activation energy from 0-37°C was 
observed for other slowly transported ions such as 
I- or sulfate [39-431. 
Cholesterol has been shown to expand the red 
cell surface area. Cholesterol enters the outer 
leaflet of the bilayer preferentially [8,44] but can 
cross the bilayer quite rapidly [20,21]. The enrich- 
ment of cholesterol in the membrane increases 
lipid order, but may also affect the exposure of 
membrane proteins including Band 3, the anion 
transport protein [22]. Cholesterol has been sug- 
gested to bind directly to Band 3 [46]. The protein 
was prepared in this study by extraction with 92% 
acetic acid and the protein is highly aggregated 
[47]. This may lead to trapping of lipids, including 
cholesterol. Varying the cholesterol content of the 
erythrocyte membrane, on the other hand, had no 
effect on the rotational diffusion of Band 3 [48]. In 
order to study the specificity of the effect of 
cholesterol on Band 3 and anion transport, the ef- 
fect of a cholesterol derivative, cholestenone, on 
anion transport was determined. 
Under appropriate conditions, cholesterol ox- 
idase converts the total cholesterol content of red 
cell membranes to cholestenone [20,21]. The effect 
of this conversion on phosphate uptake was deter- 
mined. As shown in table 2, conversion of 
cholesterol to cholestenone had a slight stimulating 
effect on phosphate uptake. This shows that there 
is not a strict requirement for cholesterol in anion 
transport and that cholestenone can substitute for 
cholesterol in the membrane. Red cells were also 
enriched with cholestenone directly and the effect 
on anion transport was determined (table 3). The 
incubation with cholestenone-containing lipo- 
somes resulted in replacement of membrane 
cholesterol by cholestenone and an increase in the 
overall steroid content of the membrane (table 3). 
The decrease in membrane cholesterol normally 
resulted in a stimulation of transport (fig.1). The 
incorporation of cholestenone into the membrane, 
however, resulted in inhibition of phosphate up- 
take (table 3), although the cholesterol level was 
lower. This suggests that cholestenone is similar to 
cholesterol in its inhibitory effect on transport. 
Since cholesterol and cholestenone had similar ef- 
fects on phosphate uptake, this suggests that any 
interaction between the steroid and Band 3 does 
not require an hydroxyl group at position 3 on the 
A ring. This limits the interaction to one exclusive- 
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Table 2 
Effect of cholesterol oxidase treatment of red blood cells on phosphate uptake 
Buffer” Cholesterol % Cholesterol tl/ 
oxidase oxidized (min) 
(NJ/ml) 
Phosphate-buffered saline, 
pH 7.4 0 0 12.0 
0.5 mM Sodium phosphate, 
310 mM sucrose, pH 7.4 0 0 12.2 
0.5 mM Sodium phosphate, 
310 mM sucrose, pH 7.4 1 50 12.2 
0.5 mM Sodium phosphate, 
310 mM sucrose, pH 7.4 2 61 11.7 
0.5 mM Sodium phosphate, 
310 mM sucrose, pH 7.4 4 90 11.3 
’ Buffer in which the cholesterol oxidase treatment was performed 
June 1983 
ly of a hydrophobic nature, and indicates a lack of 
specific interaction. The 3 ‘-OH of cholesterol 
may, however, be required for the characteristic 
ordering effect of cholesterol on fluid 
phospholipid membranes [49]. Cholesterol 
analogues have effects on the passive permeability 
of red cells. For example, the rates of penetration 
of glycerol in red blood cells was higher in the 
presence of 3-keto steroids compared to 3,& 
hydroxy steroids [19], suggesting that 3-keto 
steroids such as cholestenone disorder the 
liquid-crystalline membrane lipids. The integrity 
of the membrane of vesicular stomatitis virus was 
not greatly altered by cholesterol oxidase treatment 
1501 *
Table 3 
Effect of cholestenone nrichment on phosphate uptake 
Cholesterol :cholestenone : phospholipid Relative 
(Molar ratio) transport 
Liposomes Membranes rate 
_ 
0 :o:o 0.8 :0 :l 1.0 
2.5:O: 1 ( 5 h)’ 1.2o:o :l 0.81 
0.5 : 1: 1 ( 5 hY 0.62:0.54: 1 0.8 
0.5 : 1: 1 (20 h) 0.58:0.60: 1 0.60 
a Incubation time of cells with liposomes 
Band 3 must undergo a conformation change in 
order to change the orientation of the anion bin- 
ding site from one side of the membrane to the 
other. This conformational change may be readily 
accommodated in a membrane composed of 
0.8 mol cholesterol/mol phospholipid. An in; 
crease in the cholesterol evel of the membrane will 
increase the probability of cholesterol being a com- 
ponent of the lipid at the Band 3 protein-lipid in- 
terface. The rigid steroid ring structure may 
restrict the conformational change that occurs 
upon transport compared to the more flexible acyl 
chains of phospholipids. It is unlikely that the in- 
creased cholesterol level in the membrane in- 
fluences the oligomeric structure of Band 3. 
Cholesterol has been shown not to affect the rota- 
tion of Band 3 in the membrane [48] suggesting 
that a dramatic rearrangement of the protein 
oligomers does not occur. 
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